pd 98059 has been researched along with Neoplasms, Cystic, Mucinous, and Serous in 1 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
Neoplasms, Cystic, Mucinous, and Serous: Neoplasms containing cyst-like formations or producing mucin or serum.
| Excerpt | Relevance | Reference |
|---|---|---|
| "BACKGROUND Ovarian cancer commonly presents at a late stage and is associated with poor prognosis." | 1.51 | Expression of Dual-Specificity Phosphatase 2 (DUSP2) in Patients with Serous Ovarian Carcinoma and in SKOV3 and OVCAR3 Cells In Vitro. ( Ding, X; Liu, W; Tian, X; Zhang, L, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, W | 1 |
| Tian, X | 1 |
| Ding, X | 1 |
| Zhang, L | 1 |
1 other study available for pd 98059 and Neoplasms, Cystic, Mucinous, and Serous
| Article | Year |
|---|---|
Expression of Dual-Specificity Phosphatase 2 (DUSP2) in Patients with Serous Ovarian Carcinoma and in SKOV3 and OVCAR3 Cells In Vitro.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Dual Specificity Phosphatase 2 | 2019 |